Hoskisson Lab in the Strathclyde Institute of Pharmacy and Biomedical Sciences at the University of Strathclyde
Orchid ID: 0000-0003-4332-1640
Research in my laboratory is focussed on the evolution of metabolism and biosynthesis of specialised metabolites. The bacterial genus Streptomyces is the main focus of work in my research group due to its industrial importance, being responsible for producing around two thirds of all commercially important antibiotics as well as numerous anti-fungal, anti-helminthic and anti-cancer drugs. We also work on the bacterial pathogen Corynebacterium diphtheriae, the causative agent of diphtheria, trying to understand genome dynamics and how this contributes to pathogenicity.
We also have an interest in the genomics of Actinobacteria and the exploitation of amphibian proteins for biotechnology.
We use a range of techniques to study the biology of actinobacteria including molecular genetics, protein biochemistry, genomics, microscopy, physiology, advanced spectroscopy, mathematical modeling and bioinformatics.
I was elected as a member of the Royal Society of Edinburgh Young Academy of Scotland in 2014 and a Fellow of the Royal Society of Biology (FRSB) in 2016.
In 2017 I was elected to Royal Society of Biology council.
I am a member of the Microbiology Society, the American Society of Microbiology, the Biochemical Society, The Royal Society of Biology, and British Herpetological Society. I sat on the Microbiology Society Council (2007-2016) and I was chair of the Microbiology Society Communications Committee (2012-2016).
I am a managing editor for Antonie van Leeuwenhoek International Journal of Microbiology, and sit on the editorial board for Microbial Genomics, Nature Scientific Data and Nature Scientific Reports. I am a former Editor in Chief of Microbiology Today.